Robert Richmond, DO
Cardiovascular Disease · Burlington, WINPI 1689930612
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (57.1%), food and beverage and education — rather than concentrated in one kind of arrangement. 5 manufacturers reported payments, led by Medtronic at 58.3% of the total. Reporting peaked in 2019 at $2,658 and has fallen 95.8% since, to $111 in 2024.
Across 24 payments — averaging $123.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$2K
- Medical Device Business Services, Inc.$932
- W. L. Gore & Associates, Inc.$138
- Shockwave Medical, Inc$111
- Abbott$56
What the payments were for
- Travel & lodging$1,69357%
- Food & beverage$1,21541%
- Education$562%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(2 entities) | 15 | $1,727 |
| Medical Device Business Services, Inc. | 6 | $932 |
| W. L. Gore & Associates, Inc. | 1 | $138 |
| Shockwave Medical, Inc | 1 | $111 |
| Abbott | 1 | $56 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,963 in reported general payments places this provider in the 70th percentile of 322 cardiovascular disease providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 414 | $508,521 |
| EntrestoSacubitril/Valsartan | 48 | $71,936 |
| XareltoRivaroxaban | 52 | $67,365 |
| JardianceEmpagliflozin | 44 | $57,222 |
| BrilintaTicagrelor | 56 | $56,513 |
| Repatha SureclickEvolocumab | 37 | $35,707 |
| Praluent PenAlirocumab | 11 | $10,780 |
| VascepaIcosapent Ethyl | 11 | $9,141 |
| Metoprolol Succinate | 610 | $8,561 |
| Atorvastatin Calcium | 496 | $4,599 |
| Rosuvastatin Calcium | 370 | $3,458 |
| ClopidogrelClopidogrel Bisulfate | 278 | $2,345 |
| Ezetimibe | 129 | $2,267 |
| Losartan Potassium | 327 | $2,156 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 84 | $2,115 |
Paid to pharmacies, not to this prescriber.
Other cardiovascular disease in Burlington
- Subhashish AgarwalBrookfield$378K
- Lee BibloMilwaukee$280K
- David GrambowMilwaukee$267K
- Joshua LibermanMequon$230K
- Imdad AhmedJanesville$164K
- David MurdockWausau$164K
- Eric RobertsMilwaukee$131K
- Renuka JainMilwaukee$131K
- Evgenia RaichlinMilwaukee$73K
- Tadeo Diaz BalderramaFond du Lac$72K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.